Ganga Pharmaceuticals shareholding pattern
GANGAPHARM
12
0.00 (0.00%)Last updated on 5 Feb, 2026 | 16:00 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Summary
For Year 2025-26, Ganga Pharmaceuticals reports the following shareholding: Total Promoters at 50.91%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 49.09%. This breakdown provides a quick snapshot of ownership distribution for Ganga Pharmaceuticals in 2025-26.
Ganga Pharmaceuticals FAQs
As of 02-2026, the promoter shareholding in Ganga Pharmaceuticals stands at 50.91% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Ganga Pharmaceuticals is 0% and 0% respectively.
The retail shareholding of the Ganga Pharmaceuticals is 49.09%.
Changes in shareholding patterns of Ganga Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Ganga Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
